Annual Operating Expenses
$4.03 M
+$574.00 K+16.62%
December 1, 2023
Summary
- As of February 10, 2025, IBO annual total operating expenses is $4.03 million, with the most recent change of +$574.00 thousand (+16.62%) on December 1, 2023.
- IBO annual operating expenses is now at all-time high.
Performance
IBO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$1.13 M
+$501.00 K+80.03%
September 1, 2024
Summary
- As of February 10, 2025, IBO quarterly total operating expenses is $1.13 million, with the most recent change of +$501.00 thousand (+80.03%) on September 1, 2024.
- Over the past year, IBO quarterly operating expenses has increased by +$356.00 thousand (+46.17%).
- IBO quarterly operating expenses is now -16.08% below its all-time high of $1.34 million, reached on December 1, 2021.
Performance
IBO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
IBO Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.6% | +46.2% |
| 3 y3 years | - | +44.8% |
| 5 y5 years | +669.1% | +44.8% |
IBO Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +16.6% | -16.1% | +80.0% |
| 5 y | 5-year | at high | +669.1% | -16.1% | +568.0% |
| alltime | all time | at high | +669.1% | -16.1% | +913.5% |
Impact BioMedical Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.13 M(+80.0%) |
| Jun 2024 | - | $626.00 K(-18.8%) |
| Mar 2024 | - | $771.00 K(-32.3%) |
| Dec 2023 | $4.03 M(+16.6%) | $1.14 M(+5.7%) |
| Sep 2023 | - | $1.08 M(+6.9%) |
| Jun 2023 | - | $1.01 M(+25.5%) |
| Mar 2023 | - | $803.00 K(-22.2%) |
| Dec 2022 | $3.45 M | $1.03 M(+16.1%) |
| Sep 2022 | - | $889.00 K(+11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $800.00 K(+12.8%) |
| Mar 2022 | - | $709.00 K(-47.2%) |
| Dec 2021 | $3.45 M(+559.5%) | $1.34 M(+72.6%) |
| Sep 2021 | - | $778.30 K(+22.7%) |
| Jun 2021 | - | $634.10 K(-9.2%) |
| Mar 2021 | - | $698.00 K(+291.0%) |
| Sep 2020 | - | $178.50 K(-24.3%) |
| Jun 2020 | - | $235.80 K(+39.8%) |
| Dec 2019 | $523.70 K | $168.70 K(+51.7%) |
| Sep 2019 | - | $111.20 K |
FAQ
- What is Impact BioMedical annual total operating expenses?
- What is the all time high annual operating expenses for Impact BioMedical?
- What is Impact BioMedical annual operating expenses year-on-year change?
- What is Impact BioMedical quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Impact BioMedical?
- What is Impact BioMedical quarterly operating expenses year-on-year change?
What is Impact BioMedical annual total operating expenses?
The current annual operating expenses of IBO is $4.03 M
What is the all time high annual operating expenses for Impact BioMedical?
Impact BioMedical all-time high annual total operating expenses is $4.03 M
What is Impact BioMedical annual operating expenses year-on-year change?
Over the past year, IBO annual total operating expenses has changed by +$574.00 K (+16.62%)
What is Impact BioMedical quarterly total operating expenses?
The current quarterly operating expenses of IBO is $1.13 M
What is the all time high quarterly operating expenses for Impact BioMedical?
Impact BioMedical all-time high quarterly total operating expenses is $1.34 M
What is Impact BioMedical quarterly operating expenses year-on-year change?
Over the past year, IBO quarterly total operating expenses has changed by +$356.00 K (+46.17%)